Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Aug 1995):

Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.

Full Abstract

OBJECTIVE: The purpose of this trial was to investigate the short-term safety and efficacy of risperidone in the treatment of chronic tic disorders in children and adolescents. METHOD: This was an 11-week open-label trial and included seven subjects (five boys and two girls) with a mean age of 12.9 +/- 1.9 years. The sample included five patients with Tourette's syndrome and two with chronic motor tic disorder. The children were seen at baseline and for two follow-up visits. Three children had a comorbid diagnosis of obsessive-compulsive disorder (OCD). RESULTS: Clinical response, as measured by the Yale Global Tic Severity Scale and the Children's version of the Yale-Brown Obsessive Compulsive Scale, revealed a statistically significant reduction in tic scores ranging from 26% [corrected] to 66%. One of three children with comorbid OCD showed substantial improvement; the other two subjects showed no change. The most frequent side effect was weight gain, which ranged from 8 to 14 lb. CONCLUSIONS: Risperidone, a neuroleptic with both serotonin- and dopamine-blocking properties, appears to be effective in reducing tic frequency and intensity in children and adolescents with chronic tic disorders.

 

Author information

Author/s: Lombroso, P J (PJ); Scahill, L (L); King, R A (RA); Lynch, K A (KA); Chappell, P B (PB); Peterson, B S (BS); McDougle, C J (CJ); Leckman, J F (JF);

Affiliation: Child Study Center, Yale University School of Medicine, New Haven, CT 06520-7900, USA.

Grants: MH00856 (Agency:NIMH NIH HHS) ; MH30929 (Agency:NIMH NIH HHS) ; MH49351 (Agency:NIMH NIH HHS)

Journal and publication information

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

Journal: Journal of the American Academy of Child and Adolescent Psychiatry (J Am Acad Child Adolesc Psychiatry), published in UNITED STATES. (Language: eng)

Reference: 1995-Sep; vol 34 (issue 9) : pp 1147-52

Dates: Created 1995/11/09; Completed 1995/11/09; Revised 2007/11/14;

PMID: 7559308, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentIn: J Am Acad Child Adolesc Psychiatry. 1996 Jul;35(7):839-40. (PMID: 8768339)

ErratumIn: J Am Acad Child Adolesc Psychiatry 1996 Mar;35(3):394.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Antipsychotic Agents (0) ; Risperidone (106266-06-2)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

4/29/1992
12/30/2005
Higher Relevance Score (20)
Lower Relevance Score (16)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index